As previously reported, Northland analyst Nehal Chokshi upgraded Nutanix (NTNX) to Outperform from Market Perform with a price target of $97, up from $77. January quarter incremental ARR being “impressively” up 27% year-over-year signals that ARR growth is likely inflecting up and April quarter guidance that was “healthily above consensus” is pointing toward ARR growth likely inflecting up as well, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTNX:
- Nutanix: Strong Performance and Promising Prospects Justify Buy Rating
- Nutanix price target raised to $88 from $83 at Piper Sandler
- Nutanix: Strong Market Position and Growth Prospects Justify Buy Rating
- Nutanix price target raised to $85 from $75 at Wells Fargo
- Nutanix price target raised to $90 from $83 at JPMorgan